“………… fermentation bypasses most of the thorniest regulatory issues. By producing cannabinoids without any plant material, manufacturers no longer have to grapple with the highly problematic process of growing cannabis without exceeding government-limited percentages of THC. This development alone stands to unleash the full power of cannabinoids as, for the first time, full, unfettered research of cannabinoids is no longer a dreamed-of possibility but an immediate reality.
Here is the next “big news for the market”
Cannabinoids from FERMENTATION.
Yes, creating many types of cannabinoids via a fermentation process. – No more growing plants and their associated problems and costs!
But fermentation of cannabinoids presents far greater benefits than just regulatory compliance. Instead, they allow us to leap the chasm between scientific research and market supply. The reason is that cannabinoids produced through fermentation allow us to meet every major criteria of a robust ingredient supply chain—namely, consistency, scalability, purity and assured potency.”
Read more about it from here.
This fermentation process will rock the traditional cannabis market that relies on ‘growing’ plants as a source for extracting THC, CBD, CBN, CBG, CBC, CBL and other cannabinoids used for a multitude of remedies.Have your doubts? Here are five excellent reasons why creating cannabinoids from fermentation will be much more beneficial, consistent and cheaper than extracting them from plant stock.
- Forums
- ASX - By Stock
- RGT
- Trading activities
Trading activities, page-2
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.20M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 37.0¢ | $1.045K | 2.801K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1654 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 164 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1654 | 0.370 |
3 | 16972 | 0.350 |
1 | 29853 | 0.335 |
1 | 3030 | 0.330 |
1 | 14000 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 164 | 1 |
0.395 | 622 | 1 |
0.400 | 3110 | 2 |
0.410 | 5000 | 1 |
0.430 | 3323 | 2 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online